Stay updated on Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial page.

Latest updates to the Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial page
- Check7 days agoChange DetectedRevision label on the page was updated from v3.5.3 to v3.5.4, indicating a new version of the page framework. This update does not alter the study data or visible content.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe study record now shows Terminated status with participation details and the Informed Consent Form PDF added to the study documents, while the previous Active, not recruiting status was removed.SummaryDifference0.7%

- Check29 days agoChange DetectedThe page now shows an updated site revision/version identifier (from v3.5.2 to v3.5.3), indicating a background update to the ClinicalTrials.gov interface rather than a change to the clinical trial record.SummaryDifference0.1%

- Check36 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check65 days agoChange DetectedResults data were posted, including radiographic RECIST responses, pathologic response, adverse events, and survival outcomes with timing details. The update also references the associated study documents and submission dates.SummaryDifference3%

- Check72 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the study page.SummaryDifference0.1%

Stay in the know with updates to Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial page.